✦ LIBER ✦

Development of and clinical experience with capecitabine (Xeloda®) in the treatment of solid tumours

✍ Scribed by Cora N. Sternberg; Peter Reichardt; Michelle Holland

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A dose-escalation study of indisulam in

✍ Siegel-Lakhai, W S; Zandvliet, A S; Huitema, A D R; Tibben, M M; Milano, G; Girr 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 161 KB

A phase I clinical and pharmacokinetic s

✍ Delord, J P; Pierga, J Y; Dieras, V; Bertheault-Cvitkovic, F; Turpin, F L; Lokie 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Clinical study of combined use of tomude

✍ J. V. Vakhabova; N. N. Semenov; N. V. Dobrova; M. R. Lichinitser 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 232 KB

Phase one dose finding study of capecita

✍ Stokes, Zuzana (author);Symonds, Paul (author);Habeshaw, Tim (author);Reed, Nick 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Phase one dose finding study of capecita

✍ Stokes, Zuzana (author);Symonds, Paul (author);Habeshaw, Tim (author);Reed, Nick 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Vatalanib: the clinical development of a

✍ Scott, Edwina N; Meinhardt, Gerold; Jacques, Christian; Laurent, Dirk; Thomas, A 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 276 KB